Abstract Development of the human immunodeficiency virus type-1 (HIV-1) vaccine is an
effective and powerful prevention method of the halting pandemic of the acquired …

The development of efficient vaccine approaches against HIV infection remains challenging
in the vaccine field. Here, we developed an Ebola virus envelope glycoprotein (EboGP) …

The development of an effective vaccine against HIV infection remains a global priority.
Dendritic cell (DC)-based HIV immunotherapeutic vaccine is a promising approach which …

In the prevention of epidemic and pandemic viral infection, the use of the antiviral vaccine
has been the most successful biotechnological and biomedical approach. In recent times …

DNA vaccines expressing the envelope (env) of the human immunodeficiency virus type 1
(HIV-1) have been relatively ineffective at generating strong immune responses. In this …

Extensive glycosylation and variable loops of the HIV envelope protein (Env) are reported to
shield some neutralizing epitopes. Here, we investigated the immunogenicity of mutated HIV …

DNA vaccines require significant engineering in order to generate strong CTL responses in
both non-human primates and humans. In this study, we designed a clade C env gene …

Several conserved neutralizing epitopes have been identified in the HIV Env protein and
among these, the MPER of gp41 has received great attention and is widely recognized as a …

Ebola virus (EBOV) of the genus Ebolavirus belongs to the family Filoviridae, which cause
disease in both humans and non-human primates. Zaire Ebola virus accounts for the highest …

Evaluation of: Mohan GS, Li W, Ye L, Compans RW, Yang C. Antigenic subversion: a novel
mechanism of host immune evasion by Ebola virus. PLoS Pathog. 8 (12), e1003065 (2012) …